AZAleksandr Yurievich Zharikov

Aleksandr Yurievich Zharikov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandr Yurievich Zharikov has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EFFECT OF COMBINED ADMINISTRATION OF THE TRIPEPTIDE LEU-ILE-LYS AND INDOMETHACIN ON THE GASTRIC MUCOSA IN AN EXPERIMENT

    by Alexander Yu. Zharikov, Igor P. Bobrov, Artem S. Kalnitsky, Ekaterina O. Nazarova, Ksenia S. Rudenko, Sofia N. Nurzai, Ivan E. Gossen

    Introduction. Non-steroidal anti-inflammatory drugs represent a commonly prescribed category of pharmacologically active agents. A notable adverse effect associated with these medications is their potential to induce ulcers. Previously, researchers at Altai State Medical University developed a tripeptide, Leu-Ile-Lys, which exhibited an anti-ulcer effect in experimental settings following 7 days of administration prior to the induction of indomethacin-induced gastropathy. To comprehensively evaluate the preclinical characteristics of this tripeptide, it is essential to investigate its efficacy when administered concurrently with indomethacin. Objective. The aim of this study is to examine the impact of the simultaneous administration of the Leu-Ile-Lys tripeptide and indomethacin on the gastric mucosa in experimental conditions. Materials and Methods. The study involved 24 Wistar rats, which were allocated into a control group, an experimental group, and a comparison group. All subjects received intragastric indomethacin (6.3 mg/kg) for a duration of 7 days. In the experimental group, indomethacin was co-administered with 11.5 mg/kg of the tripeptide, while the comparison group received omeprazole (37 mg/kg). A pathomorphological examination of the stomachs of the experimental rats was performed to assess the extent of mucosal injury, the density and composition of the inflammatory infiltrate, and the level of DNA accumulation. Results. Following the 7-day co-administration of both the Leu-Ile-Lys tripeptide and omeprazole alongside indomethacin, no erosive or ulcerative damage to the gastric mucosa was observed, in contrast to the control group. The thickness of the gastric mucosa in the experimental group was significantly greater, exceeding that of the control group by a factor of 2.2 and the comparison group by a factor of 1.6. The proportion of degranular type cells in the experimental group was statistically significantly reduced compared to the control group by a factor of 2.4, and compared to the comparison group by a factor of 1.2. The DNA accumulation index observed in the experimental group exceeded that of the control group by a factor of 1.2, and was greater than that of the comparison group by a factor of 1.1. Conclusion. The simultaneous administration of the Leu-Ile-Lys tripeptide alongside indomethacin in laboratory rats mitigated the ulcerogenic effects associated with indomethacin, which was accompanied by a proliferative response.

  • Изучение токсичности трипептида Leu-Ile-Lys при однократном введении грызунам

    by Александр Юрьевич Жариков, Артем Сергеевич Кальницкий, Игорь Петрович Бобров, Олеся Николаевна Мазко, Ганна Викторовна Жарикова, Екатерина Олеговна Назарова, Анастасия Евгеньевна Колесникова, Юлия Артемовна Антонова, Ангелина Олеговна Гильмиярова

    Проведено изучение токсичности трипептида Leu-Ile-Lys при однократном внутрижелудочном введении в дозе 2000 мг/кг мышам и крысам (самцы и самки поровну). Введение Leu-Ile-Lys мышам и крысам в дозе 2000 мг/кг не вызвало гибели животных, а также проявлений токсичности. Масса тела экспериментальных животных не имела статистически значимых межгрупповых различий. При патоморфологическом исследовании внутренних органов каких-либо патологических изменений обнаружено не было. Таким образом, трипептид Leu-Ile-Lys относится к IV классу опасности (малоопасные вещества). Полученные данные свидетельствуют о перспективе клинического применения указанного соединения.

  • Effect of the tripeptide Leu-Ile-Lys on the gastric mucosa in an experiment

    by A.YU. Zharikov, О.N. Mazko, I.P. Bobrov, А.S. Kalnitsky, S.N. Nurzai, G.V. Zharikova, E.O. Nazarova, K.S. Rudenko

    Introduction. The high prevalence of gastric ulcer, as well as its multiple etiologies substantiate the urgency of developing new drugs effective in this condition. Previously, the antiulcer effect of the tripeptide Leu-Ile-Lys (LK-3) was revealed under experimental conditions in gastropathies of various origins. To clarify the mechanism of action of this compound, an in-depth experimental study of its effects on the gastric mucosa (GM) is necessary. Aim. To study the effect of the tripeptide LK-3 on GM under experimental conditions. Materials and methods. The experiment was performed on 16 Wistar rats. All animals were divided into two groups: the intact group and the group with intragastric administration of the tripeptide LK-3 (for 7 days, 11,5 mg/kg). Pathomorphological examination of the stomachs of experimental rats was performed. A histological picture of the GM was examined, and its thickness was measured. In addition, the density and composition of the inflammatory infiltrate, as well as the DNA replication index in the nuclei of cervical GM cells were determined. Results. During gross and microscopic examination, no pathological changes in the GM were revealed in either experimental group. The tripeptide LK-3 administration caused a statistically significant increase in GM thickness, by 1,4 times, compared to the intact group. In addition, the DNA replication ratio in cervical GM cells in rats treated with LK-3 was 1,2 times higher than in intact animals. At the same time, 100% of the cells studied were in the S-phase of the cell cycle after administration of LK-3, compared to 75% in the intact group. Conclusion. A 7-day intragastric administration of the tripeptide LK-3 (11,5 mg/kg) to rats caused an increase in GM thickness and in the proportion of cells in the S-phase of the cell cycle.

  • Open Access

    EFFECT OF LEU-ILE-LYS TRIPEPTIDE ON EXPERIMENTAL HISTAMINE-INDUCED GASTROPATHY

    by Alexander Yu. Zharikov, Olesya N. Mazko, Igor P. Bobrov, Artem S. Kalnitsky, Ganna V. Zharikova

    Introduction. The high prevalence of gastric ulcer, a polyethological disease formed due to increased hydrochloric acid and/or violation of protective properties of the gastric mucosa, determines the urgency of developing new drugs with an anticarcinogenic effect. According to the results of research conducted at the Altai State Medical University, the tripeptide Leu-Ile-Lys was obtained, which was successfully tested under experimental conditions against the background of gastropathies caused by the administration of drugs that directly or indirectly reduce the protective properties of the gastric mucosa. In the next stage of the preclinical study of the anti-ulcer properties of this compound, it is necessary to test it against the background of gastropathy induced by the administration of histamine, a substance that stimulates the gastric secretion of hydrochloric acid. Objective. To study the effect of the Leu-Ile-Lys tripeptide on the course of experimental histamine-induced gastropathy. Materials and Methods. Stock Wistar rats were used as a biological model for the study. The animals were divided into the control group, the Leu-Ile-Lys tripeptide administration group (11.5 mg/kg) and the omeprazole comparison drug administration group (37 mg/kg). These substances were administered intragastrically for 7 days. Histamine-induced gastropathy was simulated in animals of all groups. Subsequently, the stomachs of experimental rats were extracted to study the pathomorphological signs of the pathology. Results. When histamine-induced gastropathy in the control group, broad surface erosions of the gastric mucosa were revealed, as well as dystrophy and necrobiosis of the integumentary pit epithelium with the development of lymphoplasmocytic infiltration. Against this background, with the administration of Leu-Ile-Lys tripeptide and omeprazole, the morphological picture of the gastric mucosa was close to normal. In the Leu-Ile-Lys tripeptide group, the thickness of the gastric mucosa increased statistically significantly by 1.1 times relative to the control, while in the indicator omeprazole group, the value studied indicator was statistically significantly lower than in the Leu-Ile-Lys tripeptide group by 1.3 times, and in untreated rats by 1.2 times. Conclusion. Thus, the Leu-Ile-Lys tripeptide demonstrated an anti-ulcerative effect against the background of histamine-induced gastropathy, which was accompanied by an increase in the thickness of the gastric mucosa relative to disease control and the omeprazole administration group.

  • Open Access

    DIURETIC ACTIVITY OF BENZOYLTEOPHYLLINE

    by Alexander Yu. Zharikov, Sergey V. Sysolyatin, Sofia N. Nurzai, Artem S. Kalnitsky, Darya A. Kulagina, Anna N. Yaremenko

    Introduction. The study is devoted to the study of the diuretic activity of benzoyl theophylline, a derivative of theophylline with high calculated diuretic activity, in an animal experiment, the prediction of which was made using the PASS Online service. Objective. The aim of the study was to study the effect of benzoyl theophylline on the excretory function of the kidneys of rats. Materials and Methods. The experiments were conducted on 18 male stock Wistar rats aged 2-3 months and weighing 250-300 g, which were divided into 2 groups: the control (intact rats) and the benzoylteophylline group. The duration of the experiment was 12 days, of which, in the first 10 days, benzoyl theophylline was administered daily intragastrically at a dose of 15 mg/kg, after which the administration of the substance was discontinued in the final 2 days. Daily urine was collected and the renal excretion of Na+, K+, and creatinine ions was measured. Statistical processing of the obtained data was carried out using nonparametric methods of statistical analysis. Results. It was found that as a result of 10-day administration of benzoyl theophylline, a consistent increase in daily diuresis in rats was observed by 4.9 times, from 5.5 (2.5;9.7) ml/day at baseline to 26.8 (9.0;30.7) ml/day on day 10 (p=0.008). As a result, the level of diuresis in the benzoyl theophylline group was 5.7 times higher than in intact rats (p=0.008). In the control group, the level of diuresis did not change throughout the experiment. Urinary excretion of sodium and potassium in the benzoyl theophylline group increased 5.8-fold (p=0.008) and 8.8-fold (p=0.008), respectively, relative to baseline levels during the experiment. In the control group, the level of renal excretion of sodium and potassium remained stable throughout the experiment. Renal creatinine excretion in all three experimental groups remained unchanged throughout the experiment. Conclusion. As a result of the study, the presence of pronounced diuretic activity in benzoylteophylline was revealed. Further research will focus on a deeper study of the pharmacokinetics and pharmacodynamics of benzoylteophylline in order to create a new diuretic drug based on it.

  • EVALUATION OF THE EFFICACY OF LEU-ILE-LYS TRIPEPTIDE IN THE CONTEXT OF CHRONIC ACETATE-INDUCED GASTROPATHY

    by Alexander Yu. Zharikov, Olesya N. Mazko, Igor P. Bobrov, Artem S. Kalnitsky, Ganna V. Zharikova, Anastasia E. Kolesnikova, Ekaterina O. Nazarova, Yulia A. Antonova, Anna A. Skokova

    Introduction. Peptic ulcer is a common multifactorial disease that significantly reduces the quality of life of a large number of patients. An obligatory stage in the development of new methods of pharmacological correction of this pathology is their experimental testing on models of acute and chronic gastropathy. Previously, studies were conducted on the basis of the Altai State Medical University, which demonstrated the Leu-Ile-Lys antiulcer effect of the tripeptide on models of acute gastropathy: indomethacin, ethanol and predniolone. For a complete preclinical assessment of the test substance, it is necessary to test it under conditions of modeling chronic gastric ulceration modeling. Objective. Study of the effect of Leu-Ile-Lys tripeptide on the course of experimental chronic "acetate" gastropathy. Materials and methods. The experiments were carried out on stock Wistar rats, divided into a disease control group, a treatment group that received Leu-Ile-Lys tripeptide at a dose of 11.5 mg / kg and a comparison group administered omeprazole at a dose of 37 mg/kg. In all groups, chronic acetate gastropathy was simulated, followed by intragastric administration of the studied substances for 5 days. At the end of the experiment, the stomachs of the experimental animals were extracted, revealing macro- and microscopic signs of the development of the pathological process. Results. The size of ulcerative defects compared to the same indicator of the disease control group was significantly decreased by 2.5 times in rats treated with the Leu-Ile-Lys tripeptide, while against the background of omeprazole administration it decreased by 1.7 times. According to the results of a pathohistological study in the Leu-Ile-Lys tripeptide treatment group, a decrease in inflammatory infiltration was recorded in the area of ulcerative defects, an increase in the number of collagen fibers and an increase in angiogenesis processes relative to the disease control groups and the administration of omeprazole. Conclusion. Thus, during the experimental testing of the Leu-Ile-Lys tripeptide against the background of chronic "acetate" gastropathy, the presence of an antiulcer effect of the substance under study was revealed, which is characterized by a decrease in the size of ulcerative defects, as well as activation of regeneration processes.

  • Open Access

    Comparative pathomorphological picture of various experimental models of gastric ulcer disease

    by A. Yu. Zharikov, O. N. Mazko, I. P. Bobrov, A. S. Kalnitsky

    The aim of the study was to evaluate the pathomorphological picture of experimental models of gastric ulcer obtained by intragastric administration of ethanol of various concentrations, wormwood bitter herb tincture, as well as prednisone. Materials and methods. The experiment was conducted on 5 experimental groups of 5 stock Wistar rats. Gastric ulcer was modeled by a single injection of 96% and 70% ethanol, wormwood bitter herb tincture made with 70% ethanol, as well as 4- and 7-day administration of prednisone. Ulcerogenic agents were administered intragastrically, ethanol and wormwood bitter herb tincture at a dose of 5 ml / kg, prednisolone at a dose of 20 mg / kg. A pathomorphological study of the stomachs of experimental rats was performed at the macro- and microscopic level. Results. With intragastric administration of 96% and 70% ethanol, as well as wormwood bitter herb tincture, there is a pronounced formation of erosions with an average depth of 358.5 ± 29.7, 199.9 ±22.0 and 307.8 ± 7.5 microns, respectively, the development of foci of thrombosis and diapedetic hemorrhages, as well as necrotic-dystrophic lesions, most pronounced with the introduction of 96% ethanol. Against the background of 7-day intragastric administration of prednisolone, a significant ulcer with an average erosion depth of 164.8 ± 10.8 microns is formed in the absence of pathological changes with 4-day administration. Conclusion. The pathomorphological picture of gastric ulcer with the introduction of 70% ethanol is characterized by significant erosion with less pronounced tissue necrosis compared with 96% ethanol. The introduction of wormwood bitter herb tincture is characterized by a tendency to form erosion of coolant of greater depth than against the background of the introduction of 70% ethanol. Intragastric administration of prednisone for 7 days makes it possible to reliably obtain erosive damage to the stomach.

  • Влияние трипептида Leu-Ile-Lys на течение «этаноловой» и «преднизолоновой» гастропатии в эксперименте

    by Олеся Николаевна Мазко, Александр Юрьевич Жариков, Игорь Петрович Бобров, Артем Сергеевич Кальницкий

    Проведена оценка гастропротекторной активности трипептида Leu-Ile-Lys на фоне экспериментальной «этаноловой» и «преднизолоновой» гастропатии у крыс. Для каждой экспериментальной модели выделяли контрольную и опытную группы, а также группу сравнения. Трипептид Leu-Ile-Lys (11,5 мг/кг) и препарат сравнения омепразол (37 мг/кг) вводили ежедневно внутрижелудочно в течение 7 дней. «Этаноловую» язву моделировали однократным интрагастральным введением 80 % этанола (1 мл) через 60 мин после заключительного введения объектов исследования, «преднизолоновую» — путем ежедневного интрагастрального введения преднизолона (20 мг/кг) в течение 1 недели через 60 мин после каждого введения объектов исследования. Проводили морфологический анализ слизистой оболочки желудка с определением общего числа эрозий, в том числе, с разделением на полосовидные и точечные, расчетом индекса Паулса, а также среднего значения глубины деструкций. Введение трипептида Leu-Ile-Lys в условиях «этаноловой» язвы способствовало уменьшению средней глубины деструкций на 15,3 % в сравнении с контролем, и на 22,4 % относительно крыс, получавших омепразол (р ≤ 0,05). При моделировании «преднизолоновой» язвы в условиях введения как трипептида Leu-Ile-Lys, так и омепразола развития деструкций слизистой оболочки желудка не отмечали. Таким образом, трипептид Leu-Ile-Lys облегчает течение «этаноловой» гастропатии, оказывая выраженное гастропротекторное действие на фоне «преднизолоновой» гастропатии.

  • Open Access

    Effect of Carnosine on Oxidative Damage to the Kidneys in Experinental Diabetes Mellitus

    by A. Yu. Zharikov, S. O. Filinova, O. N. Mazko, I. P. Bobrov, O. G. Makarova, A. S. Kalnitsky

    Влияние карнозина на оксидативное повреждение почек при экспериментальном сахарном диабете

  • Open Access

    STUDY OF THE CYTOTOXICITY OF LEU-ILE-LYS TRIPEPTIDE

    by Altai State Medical University, Alexander Yu. Zharikov, Olesya N. Mazko, Artem S. Kalnitsky, Natalia M. Semenikhina, Ulyana S. Sergienko

    Introduction. A comprehensive study of the toxicity of new pharmacologically active substances is a necessary step for their introduction into practical medicine. Earlier, studies of the Leu-Ile-Lys tripeptide, which showed an anti-lithogenic effect in experimental oxalate and urate nephrolithiasis, a nephroprotective effect in experimental type 2 diabetes mellitus, as a well as gastroprotective effect in experimental "indomethacin" gastropathy, were carried out at the Federal State Budgetary Educational Institution of the Ministry of Health of the Russian Federation. Currently, there is an active development of methods for investigating the effectiveness and safety of biologically active substances in vitro, which directly assess the direct effect of the substances under study on the vital activity of cell cultures. Objective. Study of the the cytotoxicity of Leu-Ile-Lys tripeptide in cell culture. Materials and methods. Cytotoxicity was studied on human lung adenocarcinoma cell culture A549. A control group and five experimental groups were identified. Solutions of Leu-Ile-Lys tripeptide were prepared in Dulbecco's Modified Eagle's Medium culture medium with concentrations of 0.5, 1, 2, 5 and 10 mg/ml. A monolayer of cells was prepared, followed by replacement of the culture medium with solutions of the test substance, followed by 24-hour incubation in carbon dioxide at 37° C. As part of the qualitative control, the morphology and density of the monolayer were studied. Quantitative control was carried out by counting the number of cells in the Goryaev chamber. Results. No significant changes in cell morphology, monolayer density, or cell count were detected in comparison to the control in all experimental groups. Conclusion. Thus, the revealed absence of cytotoxicity of the Leu-Ile-Lys tripeptide indicates the prospects for further research of this substance in order to develop new pharmacological agents based on it.